1. Home
  2. Hashimoto's thyroiditis

Thyroid

Hashimoto's thyroiditis: what your test shows and when to treat

A guide with the guidelines in hand, including the part least often told: the cases where not treating is the right call. With a tool to place your own result.

Dr. Diegomaier Nunes NeriBy Dr. Diegomaier Nunes Neri, physician · CRM-SC 32925 | CRM-BA 39586 (Brazil) · reviewed on · 16 min read
PortuguêsEnglishEspañol
In short
  • Hashimoto's is not a synonym for hypothyroidism. Anti-TPO shows autoimmunity; whether the thyroid is coping is told by TSH together with free T4.
  • A positive anti-TPO with normal function is not treated. No guideline indicates levothyroxine in that scenario, and no treatment erases the antibody.
  • Treatment is consensus in two cases: high TSH with low free T4, and TSH above 10 mIU/L with a normal free T4.
  • Between the laboratory limit and 10, treatment is not the rule: the TRUST trial and a review of 21 studies showed no improvement in symptoms or quality of life.
  • Over-treatment harms: a suppressed TSH is associated with more atrial fibrillation, fracture and mortality. TSH also rises with age — in older people the threshold is higher.
  • In pregnancy the rules are different, and treating on the antibody alone did not improve outcomes in the TABLET trial.

You had a routine test, anti-TPO came back positive, and from there the word Hashimoto appeared. That is the most common sequence — and also the one that causes the most unnecessary alarm, because a positive antibody does not by itself mean there is a disease to treat now.

This text is about the three questions that follow: what the test is showing, when to treat and when not to treat — the part that is least often told.

What Hashimoto's thyroiditis is

It is a chronic inflammation of the thyroid driven by the person's own immune system. Lymphocytes infiltrate the gland and, over years, may reduce its ability to produce hormone. In iodine-sufficient countries it is the commonest cause of hypothyroidism (Wang et al., Front Endocrinol 2026; Caturegli et al., Autoimmun Rev 2014).

It is far more common in women — around four times as common among adults, and the gap is wider in some series (Wang et al., Front Endocrinol 2026). In the United States, the NHANES III population survey found thyroid peroxidase antibodies in 11.3% of the population and hypothyroidism (almost always subclinical) in 4.6% (Hollowell et al., J Clin Endocrinol Metab 2002 — NHANES III).

Who develops it depends on genetics plus external triggers: smoking, iodine excess, selenium deficiency, infections, some medicines and the postpartum period (Effraimidis et al., Eur J Endocrinol 2014; Hu et al., Thyroid 2017). None of them explains the disease on its own, and none of them is the patient's fault.

Hashimoto and hypothyroidism are not synonyms. Hashimoto is the autoimmune inflammation. Hypothyroidism is the thyroid producing too little hormone. Many people have the first without ever having the second.

A positive anti-TPO: what it actually means

Anti-TPO is a marker of autoimmunity, not a measure of function. It shows that the immune system recognises the thyroid, but it does not say whether the gland is coping — that is what TSH, together with free T4, tells you.

The Whickham cohort, which followed a whole population for 20 years, is the classic reference here. The annual risk of developing hypothyroidism was about 4% per year in people with both a positive antibody and a raised TSH, fell to roughly 2–3% per year with only one of the two, and was low in people with the antibody alone and a normal TSH (Vanderpump et al., Clin Endocrinol 1995 — coorte de Whickham).

In plain terms: a positive anti-TPO with normal function is a reason to monitor, not to medicate. No treatment erases the antibody, and no guideline recommends starting levothyroxine when TSH and free T4 are normal (Jonklaas et al., Thyroid 2014 — diretriz ATA).

Read your thyroid test

Enter what is on your report. The tool shows which scenario those numbers fall into according to the guidelines — so you learn the vocabulary and arrive prepared for your appointment.

This is not a diagnosis and it is not a way to diagnose yourself. It does not account for your symptoms, your other conditions, your medicines or the physical examination, and it does not replace having the report read by a doctor. No output here indicates starting, adjusting or stopping any treatment.

Ranges used: TSH 0.4 to 4.0 mIU/L (5.0 between 70 and 79 years and 6.0 from 80 on, because TSH rises with age) and free T4 0.8 to 1.8 ng/dL. Your laboratory may use different values, and a single result does not establish a diagnosis: TSH varies through the day and with acute illness, which is why it is usually repeated before any decision.

The possible scenarios, side by side

TSHFree T4What it is calledWhat the guidelines say
NormalNormalNormal function (with or without antibody)Do not treat. Monitor if anti-TPO is positive
High, below 10NormalMild subclinicalRepeat in 2–3 months. Treatment is not the rule
Above 10NormalSubclinical with high TSHTreat in most cases
HighLowOvert hypothyroidismTreat
Normal or lowLowNot the Hashimoto patternInvestigate the pituitary or the context of the sample
LowNormal or highExcess hormoneInvestigate the cause — includes too much levothyroxine

swipe the table sideways →

This table summarises what the guidelines recommend in each scenario — it is not for classifying yourself or deciding on treatment. The test is interpreted by a doctor, together with your history, your symptoms, the examination and your other results.

When to treat

There is consensus in two scenarios (Jonklaas et al., Thyroid 2014 — diretriz ATA; Pearce et al., Eur Thyroid J 2013 — diretriz ETA; Biondi et al., Endocr Rev 2019):

Outside those two, the decision stops being automatic.

When not to treat — the part almost nobody tells you

In the band between the laboratory's upper limit and 10 mIU/L, with a normal free T4, the evidence of benefit is weak. And it has been tested head-on.

TRUST, a randomised trial in 737 adults aged 65 or older with a mean TSH of 6.4 mIU/L, compared levothyroxine with placebo for a year. Levothyroxine normalised the TSH and improved neither tiredness nor hypothyroid symptoms — the two primary outcomes (Stott et al., N Engl J Med 2017 — TRUST).

A systematic review of 21 trials and 2,192 adults reached the same place: no improvement in quality of life, depressive symptoms, cognition, blood pressure or weight (Feller et al., JAMA 2018). On that basis an international panel issued a recommendation against routine treatment of subclinical hypothyroidism in most adults (Bekkering et al., BMJ 2019).

This does not mean "ignore it". It means the next step, most of the time, is to repeat the test in 2–3 months before any decision — because many mildly raised TSH values normalise on their own. What usually argues for treating even below 10: a positive anti-TPO, a younger person, clear symptoms, goitre, plans for pregnancy, and a TSH that rises on repeat (Pearce et al., Eur Thyroid J 2013 — diretriz ETA; Biondi et al., Endocr Rev 2019).

Over-treatment harms too. In a UK cohort of more than 160,000 people on levothyroxine, keeping the TSH suppressed was associated with more atrial fibrillation, more fracture and higher mortality (Thayakaran et al., BMJ 2019). The target is not "the lowest possible TSH" — it is a TSH within range.

TSH rises with age (and that changes the diagnosis)

Using one range for every age creates diagnoses where there is no disease. In the NHANES III analysis, TSH rises progressively with age even among people with no sign of thyroid disease: the 97.5th percentile goes from about 3.6 mIU/L in the twenties to over 7 mIU/L above 80 (Surks et al., J Clin Endocrinol Metab 2007).

There is more: in older people, a somewhat higher TSH is not necessarily bad. In people aged 85 and over, a higher TSH was associated with better survival, not worse (Taylor et al., J Clin Endocrinol Metab 2014). So in older age the threshold for calling it disease — and for treating — is higher.

Levothyroxine: what changes the result

When replacement is indicated, three practical things decide whether it works (Jonklaas et al., Thyroid 2014 — diretriz ATA):

On combining levothyroxine with T3: the joint consensus of the American, European and British societies does not recommend combination as routine treatment; it may be considered, as a monitored trial, in people who remain symptomatic with a normalised TSH once other causes have been excluded (Jonklaas et al., Thyroid 2021 — consenso ATA/ETA/BTA). Desiccated thyroid extract is not indicated as a first choice (Jonklaas et al., Thyroid 2014 — diretriz ATA).

Pregnancy and planning a pregnancy

Here the rules change, and change a lot. In pregnancy the normal TSH is lower, hormone requirements rise, and untreated overt hypothyroidism carries real risk for mother and baby (Alexander et al., Thyroid 2017 — diretriz ATA na gestação).

Where recent evidence was counter-intuitive is elsewhere: treating women with normal function just because anti-TPO is positive did not improve outcomes. The TABLET trial, in 952 women with positive antibodies, normal thyroid function and a history of pregnancy loss or infertility, compared levothyroxine with placebo and found no difference in live births (37.4% vs 37.9%) (Dhillon-Smith et al., N Engl J Med 2019 — TABLET). The POSTAL trial, in antibody-positive women undergoing IVF, was also negative (Wang et al., JAMA 2017 — POSTAL).

For subclinical hypothyroidism in pregnancy the picture is mixed: an Italian trial showed fewer complications with treatment (Negro et al., J Clin Endocrinol Metab 2006), while the two large US trials found no gain in the child's cognitive development at age 5 (Casey et al., N Engl J Med 2017 — ensaios do NICHD). Management is therefore individualised — a consultation discussion, not a table.

If you have Hashimoto's and want to conceive: TSH should be checked before pregnancy and as soon as pregnancy is confirmed. Women already on levothyroxine usually need a dose increase in the first weeks — that is the part that cannot wait for a second-trimester appointment (Alexander et al., Thyroid 2017 — diretriz ATA na gestação).

Weight, tiredness and what the thyroid does not explain

Hypothyroidism can contribute to weight gain, but the contribution is usually modest and largely retained fluid, and normalising TSH does not produce meaningful weight loss (Laurberg et al., Eur Thyroid J 2012). Attributing all difficulty losing weight to the thyroid tends to delay attention to what actually matters.

The same goes for tiredness: it is non-specific. Poor sleep, anaemia, iron or B12 deficiency, depression, anxiety, sleep apnoea and medication effects produce exactly the same picture — and none of them improves with levothyroxine.

Diet, selenium and supplements

Selenium lowers anti-TPO titres in several studies, but with no demonstrated clinical benefit: there is no evidence that it preserves thyroid function, reduces symptoms or changes the course of the disease (Winther et al., Nat Rev Endocrinol 2020). A gluten-free diet for people without coeliac disease, and the other restrictions circulating online, are not supported well enough to be recommended to everyone.

When to seek assessment

Without urgency, but without letting it slide: a positive anti-TPO for the first time; a TSH outside range on any test; swelling or a lump in the neck; persistent symptoms; plans for pregnancy; and any new result in someone already on levothyroxine, especially a low TSH.

Promptly: rapid weight loss, palpitation, tremor and heat intolerance; or, at the other extreme, marked drowsiness, confusion and progressive swelling.

Frequently asked questions

Does a positive anti-TPO mean I have Hashimoto's?

It means there is autoimmunity against the thyroid. If TSH and free T4 are normal, the gland is coping, and that is not a disease to treat now — it is a reason to monitor. In the Whickham cohort, the risk of progressing to hypothyroidism was low in people with the antibody alone and a normal TSH.

I have Hashimoto's. Will I need medication for life?

Only if there is hypothyroidism, and not everyone with Hashimoto's develops it. When replacement is indicated for overt hypothyroidism it is usually long term, because the cause is permanent. In mild subclinical disease, many results normalise on their own when repeated.

My TSH is 6. Do I need treatment?

In most adults, not straight away. With a normal free T4 and TSH below 10, the recommended step is to repeat in 2–3 months, because many values normalise on their own. The TRUST trial, in people with a mean TSH of 6.4, found no improvement in tiredness or symptoms with levothyroxine. Arguments in favour of treating: positive anti-TPO, younger age, goitre, plans for pregnancy and a TSH that rises on repeat.

Is there a treatment that lowers the antibody?

No treatment is approved for that purpose. Selenium lowers titres in studies but without demonstrated clinical benefit — there is no evidence that it preserves thyroid function or changes the course of the disease. Lowering the antibody number is not in itself a treatment goal.

Does Hashimoto's cause weight gain?

Hypothyroidism can contribute, but the contribution is usually modest and largely fluid retention. Normalising TSH does not produce meaningful weight loss. Attributing all the difficulty to the thyroid tends to delay attention to what actually drives weight.

Do I need to cut gluten?

Not if you do not have coeliac disease. The evidence for a gluten-free diet in Hashimoto's is weak and does not support recommending the restriction to everyone. People with Hashimoto's do have a higher risk of coeliac disease, so the route is to investigate when symptoms appear — not to cut pre-emptively.

I have Hashimoto's and want to conceive. What changes?

TSH should be checked before pregnancy and as soon as pregnancy is confirmed, because hormone requirements rise early. Women already on levothyroxine usually need an adjustment in the first weeks. Treating women with normal function simply because anti-TPO is positive did not improve live births in the TABLET trial.

Can I take levothyroxine with coffee?

Coffee taken alongside reduces absorption, as do iron, calcium, antacids and proton pump inhibitors. The fix is spacing: the tablet fasting, with water, 30–60 minutes before, or at bedtime at least 3 hours after the last meal. Consistency matters more than which time you pick.

References

  1. Wang L, Zhu X, Xu S, et al. Hashimoto’s thyroiditis: from pathogenesis to clinical management. Front Endocrinol. 2026;17. doi:10.3389/fendo.2026.1729316
  2. Caturegli P, De Remigis A, Rose N. Hashimoto thyroiditis: Clinical and diagnostic criteria. Autoimmun Rev. 2014;13(4-5):391-397. doi:10.1016/j.autrev.2014.01.007
  3. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T 4 , and Thyroid Antibodies in the United States Population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III) [NHANES III]. J Clin Endocrinol Metab. 2002;87(2):489-499. doi:10.1210/jcem.87.2.8182
  4. Vanderpump MPJ, Tunbrldge WMG, French JM, et al. The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey [coorte de Whickham]. Clin Endocrinol. 1995;43(1):55-68. doi:10.1111/j.1365-2265.1995.tb01894.x
  5. Effraimidis G, Wiersinga WM. MECHANISMS IN ENDOCRINOLOGY: Autoimmune thyroid disease: old and new players. Eur J Endocrinol. 2014;170(6):R241-R252. doi:10.1530/eje-14-0047
  6. Hu S, Rayman MP. Multiple Nutritional Factors and the Risk of Hashimoto's Thyroiditis. Thyroid. 2017;27(5):597-610. doi:10.1089/thy.2016.0635
  7. Chaker L, Bianco AC, Jonklaas J, et al. Hypothyroidism. Lancet. 2017;390(10101):1550-1562. doi:10.1016/s0140-6736(17)30703-1
  8. Jonklaas J, Bianco AC, Bauer AJ, et al. Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement [diretriz ATA]. Thyroid. 2014;24(12):1670-1751. doi:10.1089/thy.2014.0028
  9. Pearce SH, Brabant G, Duntas LH, et al. 2013 ETA Guideline: Management of Subclinical Hypothyroidism [diretriz ETA]. Eur Thyroid J. 2013;2(4):215-228. doi:10.1159/000356507
  10. Biondi B, Kahaly GJ, Robertson RP. Thyroid Dysfunction and Diabetes Mellitus: Two Closely Associated Disorders. Endocr Rev. 2019;40(3):789-824. doi:10.1210/er.2018-00163
  11. Surks MI, Hollowell JG. Age-Specific Distribution of Serum Thyrotropin and Antithyroid Antibodies in the U.S. Population: Implications for the Prevalence of Subclinical Hypothyroidism. J Clin Endocrinol Metab. 2007;92(12):4575-4582. doi:10.1210/jc.2007-1499
  12. Taylor PN, Minassian C, Rehman A, et al. TSH Levels and Risk of Miscarriage in Women on Long-Term Levothyroxine: A Community-Based Study. J Clin Endocrinol Metab. 2014;99(10):3895-3902. doi:10.1210/jc.2014-1954
  13. Stott DJ, Rodondi N, Kearney PM, et al. Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism [TRUST]. N Engl J Med. 2017;376(26):2534-2544. doi:10.1056/nejmoa1603825
  14. Feller M, Snel M, Moutzouri E, et al. Association of Thyroid Hormone Therapy With Quality of Life and Thyroid-Related Symptoms in Patients With Subclinical Hypothyroidism. JAMA. 2018;320(13):1349. doi:10.1001/jama.2018.13770
  15. Bekkering GE, Agoritsas T, Lytvyn L, et al. Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline. BMJ. 2019:l2006. doi:10.1136/bmj.l2006
  16. Rodondi N, den Elzen WPJ, Bauer DC, et al. Subclinical Hypothyroidism and the Risk of Coronary Heart Disease and Mortality. JAMA. 2010;304(12):1365. doi:10.1001/jama.2010.1361
  17. Thayakaran R, Adderley NJ, Sainsbury C, et al. Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study. BMJ. 2019:l4892. doi:10.1136/bmj.l4892
  18. Jonklaas J, Bianco AC, Cappola AR, et al. Evidence-Based Use of Levothyroxine/Liothyronine Combinations in Treating Hypothyroidism: A Consensus Document [consenso ATA/ETA/BTA]. Thyroid. 2021;31(2):156-182. doi:10.1089/thy.2020.0720
  19. Alexander EK, Pearce EN, Brent GA, et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum [diretriz ATA na gestação]. Thyroid. 2017;27(3):315-389. doi:10.1089/thy.2016.0457
  20. Dhillon-Smith RK, Middleton LJ, Sunner KK, et al. Levothyroxine in Women with Thyroid Peroxidase Antibodies before Conception [TABLET]. N Engl J Med. 2019;380(14):1316-1325. doi:10.1056/nejmoa1812537
  21. Wang H, Gao H, Chi H, et al. Effect of Levothyroxine on Miscarriage Among Women With Normal Thyroid Function and Thyroid Autoimmunity Undergoing In Vitro Fertilization and Embryo Transfer [POSTAL]. JAMA. 2017;318(22):2190. doi:10.1001/jama.2017.18249
  22. Negro R, Formoso G, Mangieri T, et al. Levothyroxine Treatment in Euthyroid Pregnant Women with Autoimmune Thyroid Disease: Effects on Obstetrical Complications. J Clin Endocrinol Metab. 2006;91(7):2587-2591. doi:10.1210/jc.2005-1603
  23. Casey BM, Thom EA, Peaceman AM, et al. Treatment of Subclinical Hypothyroidism or Hypothyroxinemia in Pregnancy [ensaios do NICHD]. N Engl J Med. 2017;376(9):815-825. doi:10.1056/nejmoa1606205
  24. Laurberg P, Knudsen N, Andersen S, et al. Thyroid Function and Obesity. Eur Thyroid J. 2012;1(3):159-167. doi:10.1159/000342994
  25. Winther KH, Rayman MP, Bonnema SJ, et al. Selenium in thyroid disorders — essential knowledge for clinicians. Nat Rev Endocrinol. 2020;16(3):165-176. doi:10.1038/s41574-019-0311-6

Read also

Important: This content is strictly educational and does not replace a consultation, a diagnosis or a prescription. It is not for self-diagnosis, nor for deciding alone whether to start, adjust or stop treatment. Responsibility for the use of this information lies entirely with the reader.

About the tool on this page. It only organises, in plain language, what the guidelines describe for each combination of results. It is not a diagnosis, it does not take into account your history, symptoms, other conditions or medicines, and it does not replace having the test read by a doctor. Reference ranges differ between laboratories, between assays, and with age and pregnancy — so the output may not fit your case.

Levothyroxine is a prescription-only medicine with an individually titrated dose. Small differences in dose change the result, and both under- and over-treatment cause harm. Never start, increase, reduce or stop levothyroxine on your own, or on the basis of this or any other text on the internet.

Written and reviewed by a physician, with primary references and verifiable DOIs. Every person is unique and must be assessed individually.

Dr. Diegomaier Nunes Neri
Dr. Diegomaier Nunes Neri

Physician (CRM-SC 32925 | CRM-BA 39586, Brazil). Sees patients by video consultation in Brazil and abroad. This content is educational, reviewed against the cited references, and does not replace a consultation.

About the author (in Portuguese)

Want your case reviewed carefully?

Video consultations in Portuguese or Spanish, for patients in Brazil and abroad.

How video consultations work

Reviewed on November 6, 2026 by Dr. Diegomaier Nunes Neri — CRM-SC 32925 | CRM-BA 39586 (Brazil).